Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Devi Lal"
Filter
Filter
Article category
Publication year
Reviews
IBD
Helminths in alternative therapeutics of inflammatory bowel disease
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
Intest Res 2025;23(1):8-22.   Published online January 12, 2024
DOI: https://doi.org/10.5217/ir.2023.00059
AbstractAbstract PDFPubReaderePub
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a nonspecific chronic inflammation of the gastrointestinal tract. Despite recent advances in therapeutics and newer management strategies, IBD largely remains untreatable. Helminth therapy is a promising alternative therapeutic for IBD that has gained some attention in the last two decades. Helminths have immunomodulatory effects and can alter the gut microbiota. The immunomodulatory effects include a strong Th2 immune response, T-regulatory cell response, and the production of regulatory cytokines. Although concrete evidence regarding the efficacy of helminth therapy in IBD is lacking, clinical studies and studies done in animal models have shown some promise. Most clinical studies have shown that helminth therapy is safe and easily tolerable. Extensive work has been done on the whipworm Trichuris, but other helminths, including Schistosoma, Trichinella, Heligmosomoides, and Ancylostoma, have also been explored for pre-clinical and animal studies. This review article summarizes the potential of helminth therapy as an alternative therapeutic or an adjuvant to the existing therapeutic procedures for IBD treatment.

Citations

Citations to this article as recorded by  
  • Recombinant Macrophage Migration Inhibitory Factor Derived from Trichinella spiralis Suppresses Obesity by Reducing Body Fat and Inflammation
    Seo Yeong Choi, Mi-Kyung Park, Yu Jin Jeong, Dong Gyu Han, Chaeeun Jin, Chang Woo Han, Se Bok Jang, Shin Ae Kang, Hak Sun Yu
    International Journal of Molecular Sciences.2026; 27(2): 887.     CrossRef
  • Anti-Inflammatory Effect of Excretion-Secretion Products of Clinostomum marginatum (Digenea: Clinostomidae) and Its Effect over the Viability and Antioxidative Activity of a Mix of Lactobacillus and/or Bifidobacterium
    María Angélica Gutiérrez-Nava, Raquel González-Vázquez, Miguel Ángel Mosqueda-Cabrera, Daniela Reyna-González, Felipe Mendoza-Pérez, Eduardo Zúñiga-León, Leovigildo Mateos-Sánchez, Pedro A. Reyes-Castillo, Rosa González-Vázquez, María Guadalupe Córdova-Es
    Microorganisms.2026; 14(2): 354.     CrossRef
  • Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease
    Ying Zhao, Lijun Ning, Yuqing Yan, Jinmei Ding, Bin Yu, Pengjie Yang, Nan Shen, Baoqin Xuan, Zhenyu Wang, Yue Zhang, Yi-Lu Zhou, Yuqi Shao, Yi Jiang, Yanru Ma, Xiaoqiang Zhu, Xiaowen Huang, Muni Hu, Chaoqin Shen, Danfeng Sun, Jianyong Sun, Ruogu Li, Sheng
    Cell Host & Microbe.2026; 34(4): 620.     CrossRef
  • The TPx Protein of Cysticercus cellulosae Promotes an IL-10–Producing Regulatory B Cell Phenotype in Human B Lymphoblastoid Cells via the cAMP/CREB Pathway
    Haojun Cai, Xue Li, Haiting Xiong, Qianqian Mu, Biying Zhou
    Cells.2026; 15(16): 1429.     CrossRef
  • In vivo reduction of Treg expansion in rodent helminth–malaria coinfection
    Luc Bourbon, Aloïs Dusuel, Nicolas Pernet, Mickaël Rialland, Benjamin Roche, Bruno Faivre, Gabriele Sorci
    Parasites & Vectors.2026;[Epub]     CrossRef
  • Dietary tryptophan ameliorates metalaxyl-induced colitis by restoring microbial tryptophan metabolism and aryl hydrocarbon receptor activation
    Wei Sun, Yu Wang, Xin Zhang, Yifan Yue, Xiaoxuan Sun, Jiyan Miao, Shihang Han, Zhiqiang Zhou, Xiuguo Wang, Wentao Zhu
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Generation of Immune Modulating Small Metabolites—Metabokines—By Adult Schistosomes
    Patrick J. Skelly, Akram A. Da’dara
    Pathogens.2025; 14(6): 526.     CrossRef
  • An experimental study of the dual modulation of the colchicine-induced rat model of Alzheimer’s disease by superparamagnetic iron oxide nanoparticles (SPIONs) and the soluble product of Dipylidium caninum adult worm
    Amal M. Elsharkawy, Faika Hassanein, Samia S. Abouelkheir, Inas M. Masoud, Wael Felefel, Inas E. Darwish, Abdelfattah Selim
    PLOS One.2025; 20(6): e0324191.     CrossRef
  • The Impact of Helminths on Colorectal Cancer: From Infections to the Isolation of Biotherapeutics
    Cuauhtémoc Ángel Sánchez-Barrera, Karen V. Fernandez-Muñoz, Mónica G. Mendoza-Rodríguez, María T. Ortiz-Melo, Jazmín A. Carrillo-Pérez, Miriam Rodríguez-Sosa, Luis I. Terrazas
    Pathogens.2025; 14(9): 949.     CrossRef
  • Advancements in therapeutic strategies and drug development for inflammatory bowel diseases
    Yu Zhou, Fang Shen
    Exploration of Immunology.2025;[Epub]     CrossRef
  • 25,069 View
  • 529 Download
  • 11 Web of Science
  • 10 Crossref
Close layer
IBD
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
Intest Res 2024;22(1):15-43.   Published online November 8, 2023
DOI: https://doi.org/10.5217/ir.2023.00080
AbstractAbstract PDFPubReaderePub
Inflammatory bowel disease (IBD) is a multifactorial disease, which is thought to be an interplay between genetic, environment, microbiota, and immune-mediated factors. Dysbiosis in the gut microbial composition, caused by antibiotics and diet, is closely related to the initiation and progression of IBD. Differences in gut microbiota composition between IBD patients and healthy individuals have been found, with reduced biodiversity of commensal microbes and colonization of opportunistic microbes in IBD patients. Gut microbiota can, therefore, potentially be used for diagnosing and prognosticating IBD, and predicting its treatment response. Currently, there are no curative therapies for IBD. Microbiota-based interventions, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, have been recognized as promising therapeutic strategies. Clinical studies and studies done in animal models have provided sufficient evidence that microbiota-based interventions may improve inflammation, the remission rate, and microscopic aspects of IBD. Further studies are required to better understand the mechanisms of action of such interventions. This will help in enhancing their effectiveness and developing personalized therapies. The present review summarizes the relationship between gut microbiota and IBD immunopathogenesis. It also discusses the use of gut microbiota as a noninvasive biomarker and potential therapeutic option.

Citations

Citations to this article as recorded by  
  • Therapeutic Potential and Functional Mechanisms of Probiotics as Prospective anti-inflammatory Agents
    Ridhika Bangotra, Bisma Habib, Mohd. Younis, Gurleen Kour, Nisha Kapoor, Ritu Mahajan, Zabeer Ahmed, Bijender Kumar Bajaj
    Probiotics and Antimicrobial Proteins.2026; 18(4): 5289.     CrossRef
  • Effects of stoma discharge reinfusion on low anterior resection syndrome and the gut microbiota following sphincter-preserving surgery for middle and low rectal cancer: a randomized clinical trial
    Shiwei Zhang, Liang He, Luyao Zhang, Jianan Sun, Yanjun Wang, Meiling Wang, Yinquan Zhao, Xuan Sun, Yang Gong, Zhong Li, Yuchen Guo, Quan Wang
    Updates in Surgery.2026; 78(2): 619.     CrossRef
  • A Comprehensive Narrative Review of Potential Gastrointestinal Adverse Effects From Micro(nano) Plastic Exposure
    Priyata Dutta, Sana Rabeeah, Alejandra Vargas, Edward C. Oldfield, David A. Johnson
    Clinical Gastroenterology and Hepatology.2026; 24(4): 881.     CrossRef
  • Oxidized Wheat Germ Protein Induces Oxidative Stress and Inflammation by Altering Gut Microbiota in Mice
    Yiming Li, Wenliang Zhao, Kun Zhan, Luanfeng Wang, Fang Wang, Haizhao Song, Fei Zeng, Zebin Weng, Xinchun Shen
    ACS Food Science & Technology.2026; 6(1): 37.     CrossRef
  • Cobalamin-mediated protection of Faecalibacterium duncaniae against oxidative stress: Insights from proteomic and membrane fatty acid profiles
    Maria Alejandra de Angel Fontalvo, Simon Ménard, Rime Chebbo, Jasmina Vidic, Alban Amoros, Christine Péchoux, Lydie Oliveira Correia, Sébastien Dupont, Florence Dubois-Brissonnet, Laurent Beney, Bonastre Oliete, Jean-Marc Chatel, Sandrine Auger
    Microbiological Research.2026; 306: 128455.     CrossRef
  • Role of miR-338-3p and miR-378a-3p as regulators in Crohn's disease pathogenesis: Potential therapeutic implications in inflammatory bowel disease
    Ki-Uk Kim, Jung Min Moon, Eunsu Lim, Kang-Bin Dan, Jeongkuk Seo, Kyuwon Kim, Seung Yong Shin, Hyeyoung Min, Chang Hwan Choi
    Life Sciences.2026; 389: 124217.     CrossRef
  • Probiotic and prebiotic mechanisms in IBD-associated colorectal carcinogenesis: recent advances
    Xueru Fan, Xiaoge Wang, Yang Chao, Erping Xu
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Butyrate-Producing Bacteria as a Keystone Species of the Gut Microbiome: A Systemic Review of Dietary Impact on Gut–Brain and Host Health
    Jacob L. Snodgrass, Bisi T. Velayudhan
    International Journal of Molecular Sciences.2026; 27(3): 1289.     CrossRef
  • Relationship between the appendix and ulcerative colitis: A new discovery
    Xu-Jia Wu, Reng-Yun Xiang, Pan Gong, Qian Chen, Xue-Feng Li
    World Journal of Gastrointestinal Endoscopy.2026;[Epub]     CrossRef
  • Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients
    Asghar Ali, Khalid I. AlHussaini
    Frontiers in Microbiology.2026;[Epub]     CrossRef
  • The epidemiology of inflammatory bowel disease: exploring the impacts of environmental factors
    Jihye Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2026; 41(2): 186.     CrossRef
  • Host–microbe interaction networks revealed through gut microbiota and microRNA correlation analysis in mouse models of chronic colitis and colitis-associated cancer
    Jae Gon Lee, In Ho Kang, A-reum Lee, Eun Hye Oh, Chan Hyuk Park, Dong Soo Han, Chang Soo Eun
    Journal of Translational Medicine.2026;[Epub]     CrossRef
  • Deciphering the mitochondria–gut microbiota axis in irritable bowel syndrome: pathogenic insights and therapeutic frontiers
    Lifang Zeng, Wenpeng Zhou
    Journal of Translational Medicine.2026;[Epub]     CrossRef
  • Gut Microbiota Alterations and Dysbiosis Patterns in Pediatric Inflammatory Bowel Disease: Clinical Correlations and Therapeutic Impact
    Anda-Maria Beca, Roxana Folescu, Adina Teodora Crăciun, Laura Olariu, Ileana Enatescu, Bianca Belei, Oana Belei
    Journal of Clinical Medicine.2026; 15(4): 1589.     CrossRef
  • Maternal gut microbial legacy shapes intestinal health and susceptibility of offspring to colitis
    Ji-Min Lee, Min-Ji Kim, Hoyul Lee, Yujin Hyun, Sung-Wook Nam, Dong-Gyu Jeon, Jae-Ho Shin, Eun Soo Kim
    npj Biofilms and Microbiomes.2026;[Epub]     CrossRef
  • Study on the predictive model of response of patients with inflammatory bowel disease to infliximab treatment
    Ru Ding, Mengdi Fan, Juanjuan Gu, Zhangning Zhou
    Investigación Clínica.2026; 67(1): 57.     CrossRef
  • Тhe effect of microbiota on inflammatory processes in the intestine
    I. M. VASYLYEVA, N. V. YARMYSH, O. A. NAKONECHNA
    Experimental and Clinical Physiology and Biochemistry.2026; 104(4): 27.     CrossRef
  • Integrated multi-omics profiling of gut microbiome and metabolome in ulcerative colitis insights from the Iranian population
    Seyedeh Maryam Mousavi, Mohammad Roayaei Ardakani, Hamid Galehdari, Mehran Dorostghoal
    iScience.2026; 29(3): 114721.     CrossRef
  • Targeting Gut Microbiota in Drug Therapy: Targeting Health Through Restoration of Intestinal Viable Ecosystems (Thrive) - A New Frontier in Pharmacology
    Mehul Bhatt, Hansal Desai
    Research Journal of Pharmacognosy and Phytochemistry.2026; 18(2): 169.     CrossRef
  • Dietary potassium poly-γ-glutamate alleviates inflammatory responses in LPS-stimulated macrophages and DSS-induced acute colitis
    Jae-Chul Choi, SuHyun Hwang, Yena Oh, Hyo Jung Ku, JiHae Choi, KyungBae Lee, KwangEun Yeo, Sanghoon Park, Seong Hwan Kim, MyungSun Cho, JungMin Bae
    Journal of Functional Foods.2026; 141: 107303.     CrossRef
  • CXCL5 is associated with neutrophil-driven intestinal inflammation and IL-17-associated epithelial signaling in inflammatory bowel disease
    Jung Min Moon, Eunsu Lim, Hyeyoung Min, Kwang Woo Kim, Hyunsun Park, Seong-Joon Koh, Joo Sung Kim
    Scientific Reports.2026;[Epub]     CrossRef
  • Astaxanthin mitigates dextran sulfate sodium-induced colitis by strengthening intestinal barrier function and suppressing oxidative stress and inflammasome activation
    Kwang-Youn Kim, Hado Choi, Yun-Mi Kang, Yeon-Ji Kim, Tae In Kim, Hee-Jin Eom, Hyun Woung Shin, Sang Mok Jung, Kyungho Kim
    Journal of Functional Foods.2026; 142: 107359.     CrossRef
  • Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases
    Fatemeh Soltani-Moghadam, Hossein Samadi Kafil, Fatemeh Yeghaneh Sefidan, Javad Nezhadi, Samira Saedi, Yalda Mohammadzadeh-Asl, Simin Sattarpour, Mohammad Ahangarzadeh Rezaee
    Current Microbiology.2026;[Epub]     CrossRef
  • Specificity vs. Synergy Between Single-Strain and Multi-Strain Probiotics for Ulcerative Colitis Treatment: A Review of the Literature
    Muhammad Ikhmal Rosali, Dinesh Prasad V. Thanga Velu, Mohd Helmy Mokhtar, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar, Adila A. Hamid
    Biomedicines.2026; 14(6): 1386.     CrossRef
  • Targeting the gut-brain axis by prebiotics and probiotics: Integrating emerging strategies in IBD management
    Devanshi Gupta, Muskan Kumari Gupta, Farhaque Parveen, Aparna Agarwal
    Human Nutrition & Metabolism.2026; 45: 200369.     CrossRef
  • Reconstructing the intestinal microbiota ecological network based on graph neural network and contrastive learning: Predicting key microbiota regulatory targets in Crohn’s Disease
    Huiyi Liu
    Computational Biology and Chemistry.2026; 124: 109248.     CrossRef
  • Antibiotic Class-Specific Effects on Inflammatory Bowel Disease: Microbiome Disruption, Risk, and Recovery
    Bhargavi Rajarathinam, Pranav V. Nair, Neeraja Murali, Ganga Lekshmi, Abitha K. Sajeev, Archa B. Pillai, Anita Thomas, Sreetha Hely, Kalyani Arun, Vidhya Prakash, Bipin G. Nair, Parvathy Venugopal, Rajaguru Aradhya
    International Journal of Molecular Sciences.2026; 27(14): 6502.     CrossRef
  • A novel multi-epitope mRNA vaccine against Escherichia coli using an in silico reverse vaccinology approach
    Shakeela Parveen, Javeria Abbasi, Muhammad Hussain, Muhammad Farhan Khan, Muhammad Tayyab, Amina Parveen, Laiba Shafique
    Journal of Applied Genetics.2026;[Epub]     CrossRef
  • Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single‐centre Australian experience
    Cher Wei Chuah, Jessica Eldredge, Annabel Magoffin, Edward Vincent O'Loughlin, Calvin Joomann Park, Juliana Puppi, Susan Siew, Michael Stormon, Kunal Thacker, Shoma Dutt
    JPGN Reports.2026;[Epub]     CrossRef
  • Research Progress on the Treatment of Ulcerative Colitis with Puerarin
    亚宁 王
    Hans Journal of Medicinal Chemistry.2026; 14(03): 244.     CrossRef
  • Adjunctive nutraceutical strategies in ulcerative colitis: From molecular pathways to clinical outcomes
    Carlo Caputo, Azzurra Chiara De Maio, Angela Lombardi, Rossella Sperlongano, Michele Caraglia, Domenico Cautela
    Biomedicine & Pharmacotherapy.2026; 203: 119855.     CrossRef
  • A Multi‐Target Approach to Colitis: Ergothioneine Promotes Recovery by Restoring the Intestinal Barrier, Reducing Inflammation, and Remodeling the Microbiota
    Lin Wang, Yao Song, Yucong Wang, Zhixin Xie, Xihan Xu, Jianchun Han, Rongxu Liu
    Food Science & Nutrition.2026;[Epub]     CrossRef
  • Poricoic acid A administered during DSS exposure attenuates acute colitis in mice and is accompanied by barrier-associated changes and endpoint fecal microbiota shifts
    Mei Wang, Kunkun Zhang, Danli Wang, Mingtao Cao, Rong Yong, Xiangqian Li, Wenyi Chen, Chengcheng Peng, Jiale Chang, Lu Fang, Feiyang Zhou, Yuyue Wan, Jingran Wang, Zhi Zhou, Lin Chen
    Journal of Natural Medicines.2026;[Epub]     CrossRef
  • Long-term developmental alterations in intestinal microbiota, metabolism, and T-cell homeostasis in offspring rats following maternal tetrabromobisphenol A exposure
    Shuyang Huang, Chongxiang Zeng, Jiao Yang, Zenghua Qi, Yinfeng Zhou, Guoxia Zhang, Yingxin Yu
    Journal of Hazardous Materials.2026; 517: 143706.     CrossRef
  • Fecal microbiota fermenting simple organic carbon substrates in vitro as microbial factories capable of distinguishing Crohn’s disease from healthy states
    Anna Detman-Ignatowska, Gabriele Schiro, Rafał Filip, Emilia Samborowska, Jakub Karczmarski, Sara Jarmakiewicz-Czaja, Kinga Jakubowska, Anna Williams, Nabahi Ramos Hickman, Daniel Laubitz, Anna Sikora
    Microbial Cell Factories.2026;[Epub]     CrossRef
  • Enterotype-based stratification identifies clinically distinct microbial subtypes in inflammatory bowel disease
    Seungpyo Hong, Kwang Woo Kim, Yeram Im, Jaeyoung Jang, Dae Hee Cheon, Eun Kyoung Lee, Yoo Min Han, Jun Won Park, Hyun Jung Lee, Hyunsun Park, Seong Jin Jo, Donghyun Kim, Hyoun Woo Kang, Jong Pil Im, Eun Soo Kim, Ji Won Kim, Byeong Gwan Kim, Joo Sung Kim,
    Inflammatory Bowel Diseases.2026;[Epub]     CrossRef
  • Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
    Great Iruoghene Edo, Alice Njolke Mafe, Ali B.M. Ali, Patrick Othuke Akpoghelie, Emad Yousif, Jesse Innocent Apameio, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Yasal Garba, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Umar, Dilber Uzun Oz
    International Journal of Biological Macromolecules.2025; 289: 138633.     CrossRef
  • Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release
    Great Iruoghene Edo, Alice Njolke Mafe, Nawar. F. Razooqi, Ebuka Chukwuma Umelo, Tayser Sumer Gaaz, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Patrick Othuke Akpoghelie, Rapheal Ajiri Opiti, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Uma
    Designed Monomers and Polymers.2025; 28(1): 1.     CrossRef
  • Helminths in alternative therapeutics of inflammatory bowel disease
    Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
    Intestinal Research.2025; 23(1): 8.     CrossRef
  • Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats
    Min Cui, Wei-Ming Yang, Ping Yao
    Scientific Reports.2025;[Epub]     CrossRef
  • Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
    Linda Galasso, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Federica Vitale, Alberto Nicoletti, Mattia Paratore, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
    Cancers.2025; 17(3): 368.     CrossRef
  • Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid
    Zhuoya Wang, Tian Liu, Li Liu, Jian Xie, Furui Tang, Yimin Pi, Yuchun Zhong, Zhidong He, Wenming Zhang, Cihua Zheng
    Pharmacological Research.2025; 213: 107663.     CrossRef
  • Therapeutic systems based on natural gut microbiota modulators: the latest advances in the treatment of inflammatory bowel disease
    Zelin Guan, Peilin Niu, Qichao Tan, Yidong Wang, Shujing Deng, Danyang Wang, Kai Dong, Jianfeng Xing, Cuiyu You
    Materials Advances.2025; 6(5): 1578.     CrossRef
  • Metabolic musculoskeletal disorders in patients with inflammatory bowel disease
    Young Joo Yang, Seong Ran Jeon
    The Korean Journal of Internal Medicine.2025; 40(2): 181.     CrossRef
  • Photobiomodulation and the oral-gut microbiome axis: therapeutic potential and challenges
    Neda Hakimiha, Somayeh Jahani Sherafat, E-Liisa Laakso, Reza Fekrazad
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Dinamiche del microbioma: dai cambiamenti nel corso della vita alla disbiosi nelle patologie tumorali
    Marcella NUNZIATO
    Biochimica Clinica.2025;[Epub]     CrossRef
  • Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer
    Xilun Cui, Changfeng Li, Jing Zhong, Yuanda Liu, Pengtuo Xiao, Chang Liu, Mengwei Zhao, Wei Yang
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Metabolic Disorders and Inflammatory Bowel Diseases
    Hye Kyung Hyun, Jae Hee Cheon
    Gut and Liver.2025; 19(3): 307.     CrossRef
  • Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis
    Ji Eun Baek, Jung-Bin Park, June Hwa Bae, Min Hyun Kim, Seung Wook Hong, Sung Wook Hwang, Jong Lyul Lee, Yong Sik Yoon, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Suk-Kyun Yang, Sang Hyoung Park
    Gut and Liver.2025; 19(3): 388.     CrossRef
  • Personalized Microbiome Modulation to Improve Clinical Outcomes in Pediatric Inflammatory Bowel Disease: A Multi-Omics and Interventional Approach
    Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca, Ileana Enătescu, Laura Olariu, Oana Belei
    Microorganisms.2025; 13(5): 1047.     CrossRef
  • Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment
    Timoth Mkilima
    Annals of the New York Academy of Sciences.2025; 1548(1): 29.     CrossRef
  • Gastric Cancer and Microbiota: Exploring the Microbiome’s Role in Carcinogenesis and Treatment Strategies
    Daniela-Cornelia Lazăr, Sorin-Dan Chiriac, George-Andrei Drăghici, Elena-Alina Moacă, Alexandra Corina Faur, Mihaela-Flavia Avram, Vladiana-Romina Turi, Mihaela-Roxana Nicolin, Adrian Goldiș, Matin Asad Salehi, Radu Jipa
    Life.2025; 15(7): 999.     CrossRef
  • TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
    Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon
    Annals of Medicine.2025;[Epub]     CrossRef
  • Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
    Himani Pandey, Prabudh Goel, Varunvenkat M Srinivasan, Daryl W T Tang, Sunny H Wong, Devi Lal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • MH002, a Novel Butyrate-Producing Consortium of Six Commensal Bacterial Strains Has Immune-Modulatory and Mucosal-Healing Properties
    Iris Pinheiro, Selin Bolca, Lien Van den Bossche, Wiebe Vanhove, Sara Van Ryckeghem, Davide Gottardi, Debby Laukens, Sam Possemiers
    International Journal of Molecular Sciences.2025; 26(13): 6167.     CrossRef
  • The Role of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Livestock and Poultry Gut Health: A Review
    Taojing Yue, Yanan Lu, Wenli Ding, Bowen Xu, Cai Zhang, Lei Li, Fuchun Jian, Shucheng Huang
    Metabolites.2025; 15(7): 478.     CrossRef
  • Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies
    Siyuan Bu, Xiaozhen Cheng, Meng Chen, Yongduo Yu
    Pharmacogenomics and Personalized Medicine.2025; Volume 18: 219.     CrossRef
  • A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran
    Samira Saedi, Safoura Derakhshan, Javid Sadeghi, Alka Hasani, Manouchehr Khoshbaten, Vahdat Poortahmasebi, Somayeh Ahmadi
    Letters in Applied Microbiology.2025;[Epub]     CrossRef
  • Modulatory effects of synbiotic blend on selected human fecal bacteria and TNFα + LPS-induced inflammation in human intestinal epithelial cells
    Anita Rawat, Arka Bhattacharya, Rupa Tharu, Ruchika Maurya, Sanjay Kumar Bhadada, Mahendra Bishnoi, Kanthi Kiran Kondepudi
    The Microbe.2025; 8: 100512.     CrossRef
  • Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
    Jiyoung Yoon, Daein Kim, You Sun Kim
    Intestinal Research.2025; 23(4): 430.     CrossRef
  • Annexin A1 levels affect microbiota in health and DSS-induced colitis/inflammatory bowel disease development
    Luana Filippi Xavier, Ranko Gacesa, Gustavo Henrique Oliveira da Rocha, Milena Fronza Broering, Pablo Scharf, Fabiana da Silva Lima, Klaas Nico Faber, Hermie Harmsen, Christian Hoffmann, Sandra Helena Poliselli Farsky
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • The Effect of Cucumaria frondosa Tentacles Hydrolysates on Dextran Sulfate Sodium-Induced Colitis: Integrated Metagenomics and Metabolomics Analysis
    Senyu Zhang, Qiuting Wang, Shunmin Gong, Mingbo Li, Yu Zhang, Leilei Sun, Liqin Sun
    Foods.2025; 14(20): 3483.     CrossRef
  • The gut immune axis in ulcerative colitis: insights from microbiome research
    Rufaida Wasim
    Molecular Biology Reports.2025;[Epub]     CrossRef
  • Integrating gut microbiota and metabolomics in pediatric inflammatory bowel disease: insights into pathogenesis and potential role of precision medicine
    Rui Dong, Xiaoling Meng, Haiyan Hu, Jie Pan, Wei Wang
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases
    Yanyu Cui, Zhendong Feng, Qihan Zhao, Haoran Dai, Yang Zheng, Hongliang Rui, Baoli Liu
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Natural polyphenols in ulcerative colitis: preclinical mechanisms of action and therapeutic potential
    Chengu Niu, Jing Zhang, Patrick I. Okolo
    International Journal of Food Sciences and Nutrition.2025; 76(8): 825.     CrossRef
  • The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease
    Xingyu Shen, Yue Li, Deqiang Wang, Kang Sun
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation
    Yuyuan Hu, Yuhang Yang, Yan Li, Qiang Zhang, Wei Zhang, Jinghan Jia, Zhuoyi Han, Jinxi Wang
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer
    Devi Lal, Himani Pandey
    Onco.2025; 5(4): 50.     CrossRef
  • Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy
    Miljana Glazar, Sonia Facchin
    Academia Nutrition and Dietetics.2025;[Epub]     CrossRef
  • Editorial: Environments-pathogens-the gut microbiota and host diseases
    Jinbo Xiong, Zunji Shi
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders
    Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, Rosa Vaccaro, Ludovica Garro, Simone Carotti, Ludovica Ceci, Paolo Onori, Luigi Pannarale, Antonio Franchitto, Eugenio Gaudio, Arianna Casini
    Neurogastroenterology & Motility.2024;[Epub]     CrossRef
  • Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies
    Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, Sankha Bhattacharya, Bhupendra G. Prajapati
    ACS Pharmacology & Translational Science.2024; 7(4): 967.     CrossRef
  • Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review
    Luana Alexandrescu, Alina Doina Nicoara, Doina Ecaterina Tofolean, Alexandra Herlo, Andreea Nelson Twakor, Cristina Tocia, Anamaria Trandafir, Andrei Dumitru, Eugen Dumitru, Cristian Florentin Aftenie, Ionela Preotesoiu, Elena Dina, Ioan Tiberiu Tofolean
    International Journal of Molecular Sciences.2024; 25(15): 8451.     CrossRef
  • Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis
    Sara Deleu, Inge Jacobs, Jorge F. Vazquez Castellanos, Sare Verstockt, Bruna Trindade de Carvalho, Ana Subotić, Bram Verstockt, Kaline Arnauts, Lowie Deprez, Eva Vissers, Matthias Lenfant, Greet Vandermeulen, Gert De Hertogh, Kristin Verbeke, Gianluca Mat
    Nutrients.2024; 16(16): 2668.     CrossRef
  • The emerging role of the gut microbiota and its application in inflammatory bowel disease
    Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Anquan Shang, Francis Atim Akanyibah, Fei Mao
    Biomedicine & Pharmacotherapy.2024; 179: 117302.     CrossRef
  • Bifidogenic Effect of Human Milk Oligosaccharides on Pediatric IBD Fecal Microbiota
    Nize Otaru, Danica Bajic, Pieter Van den Abbeele, Saskia Vande Velde, Stephanie Van Biervliet, Robert E. Steinert, Ateequr Rehman
    Microorganisms.2024; 12(10): 1977.     CrossRef
  • Analysis of the Preventive Effect of Lonicera caerulea Pomace and Its Isolated Components on Colitis in Mice Based on Gut Microbiota and Serum Metabolomics
    Zinuo Zhou, Xinwen Huang, Baixi Zhang
    Antioxidants.2024; 13(12): 1478.     CrossRef
  • Gut microbiota mediated T cells regulation and autoimmune diseases
    Nabeel Khalid Bhutta, Xiujin Xu, Cuiqin Jian, Yifan Wang, Yi Liu, Jinlyu Sun, Bingnan Han, Shandong Wu, Ansar Javeed
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects
    Yibing Hu, Zhenping Wu, Xiaoyun Yang, Jin Ding, Qunying Wang, Hao Fang, Lujian Zhu, Minli Hu
    BMC Microbiology.2024;[Epub]     CrossRef
  • 38,581 View
  • 666 Download
  • 78 Web of Science
  • 80 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP